Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Fairlie

Showing results (171-180 of 326) with videos related to

Pageof 33
Sort By:
Chemical Communications (Cambridge, England)|February 15, 2013
Efficient chemical synthesis of human complement protein C3aArtin Ghassemian, Ching-I Anderson Wang, Mei-Kwan Yau, et al.
Medicinal Research Reviews|May 26, 2026
Hydroxamic Acids as HDAC Inhibitor Drug Leads for MalariaWisam A Dawood, Jacinta R Macdonald, Christian Anzenhofer, et al.
Journal of Chemical Information and Modeling|October 8, 2015
Repurposing Registered Drugs as Antagonists for Protease-Activated Receptor 2Weijun Xu, Junxian Lim, Chai-Yeen Goh, et al.
Angewandte Chemie (International Ed. in English)|May 3, 2026
Experimental Evidence for a Metal-Related Function of a CyanobactinPhilipp Baur, Timothy A Hill, Kai-Chen Wu, et al.
Journal of Medicinal Chemistry|August 19, 2022
Modifying a Hydroxyl Patch in Glucagon-like Peptide 1 Produces Biased Agonists with Unique Signaling ProfilesPeiqi Wang, Timothy A Hill, Justin Mitchell, et al.
Marine Drugs|September 27, 2023
Talarolides Revisited: Cyclic Heptapeptides from an Australian Marine Tunicate-Associated Fungus, <i>Talaromyces</i> sp. CMB-TU011Angela A Salim, Waleed M Hussein, Pradeep Dewapriya, et al.
Biopolymers|June 12, 2016
Development of cell-penetrating peptide-based drug leads to inhibit MDMX:p53 and MDM2:p53 interactionsGrégoire Philippe, Yen-Hua Huang, Olivier Cheneval, et al.
Chemical Science|February 29, 2020
Twists or turns: stabilising alpha <i>vs.</i> beta turns in tetrapeptidesHuy N Hoang, Timothy A Hill, Gloria Ruiz-Gómez, et al.
Plos One|March 25, 2021
Expression of protease activated receptor-2 is reduced in renal cell carcinoma biopsies and cell linesChristudas Morais, Retnagowri Rajandram, Jade S Blakeney, et al.
International Immunopharmacology|March 22, 2005
A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitisTrent M Woodruff, Thiruma V Arumugam, Ian A Shiels, et al.
Pageof 33

Showing results (171-180 of 326) with videos related to

Sort By:
Pageof 33
Chemical Communications (Cambridge, England)|February 15, 2013
Efficient chemical synthesis of human complement protein C3aArtin Ghassemian, Ching-I Anderson Wang, Mei-Kwan Yau, et al.
Medicinal Research Reviews|May 26, 2026
Hydroxamic Acids as HDAC Inhibitor Drug Leads for MalariaWisam A Dawood, Jacinta R Macdonald, Christian Anzenhofer, et al.
Journal of Chemical Information and Modeling|October 8, 2015
Repurposing Registered Drugs as Antagonists for Protease-Activated Receptor 2Weijun Xu, Junxian Lim, Chai-Yeen Goh, et al.
Angewandte Chemie (International Ed. in English)|May 3, 2026
Experimental Evidence for a Metal-Related Function of a CyanobactinPhilipp Baur, Timothy A Hill, Kai-Chen Wu, et al.
Journal of Medicinal Chemistry|August 19, 2022
Modifying a Hydroxyl Patch in Glucagon-like Peptide 1 Produces Biased Agonists with Unique Signaling ProfilesPeiqi Wang, Timothy A Hill, Justin Mitchell, et al.
Marine Drugs|September 27, 2023
Talarolides Revisited: Cyclic Heptapeptides from an Australian Marine Tunicate-Associated Fungus, <i>Talaromyces</i> sp. CMB-TU011Angela A Salim, Waleed M Hussein, Pradeep Dewapriya, et al.
Biopolymers|June 12, 2016
Development of cell-penetrating peptide-based drug leads to inhibit MDMX:p53 and MDM2:p53 interactionsGrégoire Philippe, Yen-Hua Huang, Olivier Cheneval, et al.
Chemical Science|February 29, 2020
Twists or turns: stabilising alpha <i>vs.</i> beta turns in tetrapeptidesHuy N Hoang, Timothy A Hill, Gloria Ruiz-Gómez, et al.
Plos One|March 25, 2021
Expression of protease activated receptor-2 is reduced in renal cell carcinoma biopsies and cell linesChristudas Morais, Retnagowri Rajandram, Jade S Blakeney, et al.
International Immunopharmacology|March 22, 2005
A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitisTrent M Woodruff, Thiruma V Arumugam, Ian A Shiels, et al.
Pageof 33